Catalent launches OneXpress to accelerate oral dosage products from clinic to launch
Catalent announces the launch of its new OneXpress service for the integrated development, scale-up and manufacturing of new oral solid dosage forms
Breaking News
XBiotech Fluvid therapy to treat influenza and COVID-19 infections
The latest research findings suggest the therapy, designed to be effective against all known strains of influenza in ...
Tracelink whitepaper reveals significant industry challenges
The COVID-19 pandemic has caused supply chain disruptions and a consequent loss of confidence for many pharma companies
Exceptional medicinal chemistry solutions
The Solutions for Medicinal Chemistry document is available to download
Manufacturing Chemist Live: Day Two Review
At the close of MCL’s second and final day, attendees have once again had the chance to enjoy engaging, interesting ...
Moderna’s COVID-19 vaccine 94.5% effective
The company plans to submit data from the full Phase 3 COVE study to a peer-reviewed publication
University of Exeter partners with MDC to accelerate medicine R&D
The partnership also produces a post-COVID blueprint for academic-Catapult collaboration to drive UK productivity
Immunotherapy: antibody drug conjugates from a small molecule perspective
Immunotherapies such as ADCs deliver a more targeted treatment against cancer that improves the quality of life for the ...
CDMOs benefit from COVID-19 impacts
CPhI’s annual report also indicates that mega-cap pharma innovation is slowing outsourcing
MercachemSyncom closes the acquisition of Admescope
Admescope brings expertise in drug metabolism, drug interactions, pharmacokinetics and quantitative bioanalysis
Manufacturing Chemist Live: Day One Review
The first day of MC Live has now concluded, with attendees enjoying presentations from STA Pharmaceuticals, NSF ...
Model-based optimisation of mixed solvent systems for spray drying
Spray drying is a common and effective approach to enhance the bioavailability of low-solubility small molecules. As ...
Coronavirus: Frontrunners approach end of Phase III trials
Pfizer and BioNTech have recently revealed promising data showing their vaccine candidate is 90% effective
Apeiron and Domainex partner to progress drug discovery
The companies have previously collaborated on hit identification, both fragment-based and virtual screening
Six projects complete inaugural bioprocessing challenge
The Testa Center, host to the challenge, was established in 2018 by the Swedish government and Cytiva
In Brief
Most Popular in Research
Featured Companies
Reports
